*001882674
*00520160622160651.0
*007ta
*008131031s2013    no#           000 u eng
*00901363cam a2200325 c 4500
*015  $a1321670$2nbf
*019  $bl
*020  $qh.
*035  $a(EXLNZ-47BIBSYS_NETWORK)991321581084702201
*035  $a(NO-LaBS)14226355(bibid)
*035  $a(NO-TrBIB)132158108
*035  $a132158108-47bibsys_network
*040  $aNO-OsNB$bnob$ekatreg
*042  $anorbibl
*044  $cno
*1001 $aBrekke, Kurt Richard$d1969-$0(NO-TrBIB)90942008$_31258800
*24510$aMargins and market shares :$bpharmacy incentives for generic substitution$cKurt Richard Brekke, Tor Helge Holmås, Odd Rune Straume
*260  $aBergen$bInstitute for Research in Economics and Business Administration$c2013
*300  $a31 bl.$bdiagr.
*4901 $aWorking paper / Institute for Research in Economics and Business Administration$vno. 8/13
*500  $aProsjektnr. : 9031
*500  $aSNF project: Improving Competition Policy
*7001 $aHolmås, Tor Helge$d1960-$0(NO-TrBIB)11046724$_34265300
*7001 $aStraume, Odd Rune$d1971-$0(NO-TrBIB)98050635$_22289500
*7102 $aImproving Competition Policy (prosjekt)$0(NO-TrBIB)11025824$_35357900
*7760 $tMargins and market shares : pharmacy incentives for generic substitution$w991405372284702201
*830 0$aWorking paper (Samfunns- og næringslivsforskning : trykt utg.)$vno. 8/13$w990208439844702201$_13111800
*901  $a90
*913  $aNorbok$bNB
*999  $aoai:nb.bibsys.no:991321581084702202$b2021-11-14T20:56:27Z$z991321581084702202
^